ZYME Zymeworks Inc.

NASDAQ
$26.04

Zymeworks Inc. (ZYME) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with ZYME's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
5 transactions
Purchases
$0
0 shares
Sales
$1.8M
68,865 shares
Net activity
-$1.8M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $1.8M 5 transactions · 68,865 shares

Largest single sale: $651.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Platshon Scott EVP, Chief Business Officer Sell 15,292 $24.95 $381.5K 21,745 −41.3% of holding
Moore Paul Andrew 3 fills Chief Scientific Officer Sell 39,741 $26.07 $1.0M 66,130 −37.5% of holding
Schayowitz Adam EVP, Head of R&D Sell 13,832 $25.85 $357.6K 23,205 −37.3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.